ARTICLE | Clinical News
Onconase: Completed Phase III trial
May 3, 1999 7:00 AM UTC
Alfacell Corp. (ACEL), Bloomfield, N.J. Product: Onconase Business: Cancer Therapeutic category: Cytotoxic Target: RNA Description: Cytotoxic ribonuclease Indication: Treat malignant mesothelioma Sta...